Related Experiment Video
Updated: Sep 17, 2025
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.2K
Contemporary CMML Risk Stratification and Management
Dahniel Sastow1, Arjun Syal2, Douglas Tremblay3
1Division of Hematology and Medical Oncology, Tisch Cancer Institute Icahn School of Medicine, Mount Sinai 1470 Madison Avenue, New York, NY, 10029, USA.
Current Hematologic Malignancy Reports
|July 4, 2025
Summary
Updated diagnostic criteria and novel therapies offer new hope for chronic myelomonocytic leukemia (CMML), a rare blood cancer. Research is advancing risk stratification and treatment options for this challenging MDS/MPN overlap syndrome.
Area of Science:
- Hematology
- Oncology
- Internal Medicine
Background:
- Chronic myelomonocytic leukemia (CMML) is a rare and heterogeneous hematologic malignancy.
- It presents diagnostic and therapeutic challenges due to its classification as a myelodysplastic/myeloproliferative neoplasm (MDS/MPN) overlap syndrome.
Purpose of the Study:
- To review updates in CMML diagnostic criteria.
- To examine risk stratification models and their clinical implications.
- To outline established and emerging therapies for CMML.
Main Methods:
- Literature review of recent advancements in CMML diagnosis and treatment.
- Analysis of updated diagnostic thresholds and risk stratification tools.
- Evaluation of current and investigational therapeutic agents.
Main Results:
- 2022 diagnostic criteria lower the monocyte threshold for CMML, potentially reclassifying MDS cases.
- Refined risk stratification models aid in patient selection for allogeneic stem cell transplantation.
- Novel therapies like lenzilumab and IO-202 show early promise, while established treatments offer limited survival benefits.
Conclusions:
- Advances in diagnostic criteria and risk stratification are crucial for managing CMML.
- There is an urgent need for novel therapeutic development due to limited efficacy of current treatments.
- Dedicated research efforts are yielding promising new agents for this rare and complex disease.
Related Concept Videos
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
39
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
39
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
180
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
127
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
127
01:15Methods of Documentation VI: Case Management Model
633
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
633
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
01:26Mitral Stenosis III: Medical Management
28
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
28